Cantor Fitzgerald Cuts Earnings Estimates for Verona Pharma
Verona Pharma plc (NASDAQ:VRNA – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Verona Pharma in a report released on Wednesday, April 30th. Cantor Fitzgerald analyst O. Brayer now expects that the company will post earnings per share of $0.10 for the year, down from their previous forecast […]
Verona Pharma plc (NASDAQ:VRNA – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Verona Pharma in a report released on Wednesday, April 30th. Cantor Fitzgerald analyst O. Brayer now expects that the company will post earnings per share of $0.10 for the year, down from their previous forecast […]
